April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Covid-19: After a brief lull, the coronavirus epidemic is starting again in France Nov 25, 2022
- Dr. Komorowski has shared an unusual way to escape the heat Jun 26, 2020
- Heatwaves and Covid-19: Health authorities estimate the excess number of deaths in France this summer at 10,420 Nov 22, 2022
- Vargas Llosa continued to write during his hospitalization for covid May 24, 2022
- Latin America seeks in Andorra how to overcome COVID-19 Apr 20, 2021
- La Plata: They deliver ballots from the Frente de Todos with bibs from the Ministry of Health and the vaccination campaign Aug 28, 2021
- Rospotrebnadzor disclosed atypical and dangerous symptoms of coronavirus Aug 29, 2021
Maxie Eckert
Today at 11:34 AM
.
